GenMont Biotech Inc Cash Flow Conversion Efficiency

Latest as of March 2026: 0.011x

GenMont Biotech Inc cash flow conversion efficiency. Based on the latest financial reports, GenMont Biotech Inc (3164) has a cash flow conversion efficiency ratio of 0.011x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$15.46 Million ≈ $487.07K USD) by net assets (NT$1.41 Billion ≈ $44.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of GenMont Biotech Inc (2005–2025)

Cash flow conversion efficiency of GenMont Biotech Inc from 2005 to 2025. This chart illustrates how GenMont Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View GenMont Biotech Inc (3164) share price today for real-time trading data and today's change.

GenMont Biotech Inc Cash Flow Conversion Ratio Explained

GenMont Biotech Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

GenMont Biotech Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of GenMont Biotech Inc ranked by their cash flow conversion efficiency. Also see GenMont Biotech Inc market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
IGM Biosciences Inc NASDAQ:IGMS	-0.503x
A.J. Plast Public Company Limited BK:AJ	0.107x
Firetrade Engineering PCL BK:FTE	0.045x
Somnomed Ltd AU:SOM	0.083x
Ortoma AB Series B ST:ORT-B	-0.120x
Burberry Group PLC LSE:BRBY	0.403x
Experience Co Ltd AU:EXP	0.044x
51 CREDIT CARD DL-00001 F:2JY	N/A

Annual Cash Flow Conversion Efficiency for GenMont Biotech Inc (2005–2025)

The table below shows the annual cash flow conversion efficiency of GenMont Biotech Inc from 2005 to 2025. Review free cash flow generation of GenMont Biotech Inc to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$1.45 Billion ≈ $45.67 Million	NT$73.60 Million ≈ $2.32 Million	0.051x	-39.40%
2024-12-31	NT$1.48 Billion ≈ $46.62 Million	NT$123.95 Million ≈ $3.90 Million	0.084x	+250.84%
2023-12-31	NT$1.45 Billion ≈ $45.66 Million	NT$34.60 Million ≈ $1.09 Million	0.024x	-74.09%
2022-12-31	NT$1.50 Billion ≈ $47.17 Million	NT$137.95 Million ≈ $4.35 Million	0.092x	+25.79%
2021-12-31	NT$1.52 Billion ≈ $48.03 Million	NT$111.66 Million ≈ $3.52 Million	0.073x	-8.23%
2020-12-31	NT$1.48 Billion ≈ $46.69 Million	NT$118.27 Million ≈ $3.73 Million	0.080x	+55.11%
2019-12-31	NT$1.45 Billion ≈ $45.62 Million	NT$74.52 Million ≈ $2.35 Million	0.051x	+43.51%
2018-12-31	NT$1.56 Billion ≈ $49.23 Million	NT$56.03 Million ≈ $1.77 Million	0.036x	-36.63%
2017-12-31	NT$1.37 Billion ≈ $43.19 Million	NT$77.56 Million ≈ $2.44 Million	0.057x	+59.70%
2016-12-31	NT$1.28 Billion ≈ $40.32 Million	NT$45.34 Million ≈ $1.43 Million	0.035x	+1161.02%
2015-12-31	NT$1.50 Billion ≈ $47.27 Million	NT$-5.01 Million ≈ $-157.84K	-0.003x	+91.40%
2014-12-31	NT$1.60 Billion ≈ $50.32 Million	NT$-62.00 Million ≈ $-1.95 Million	-0.039x	-132.38%
2013-12-31	NT$837.28 Million ≈ $26.38 Million	NT$100.37 Million ≈ $3.16 Million	0.120x	+538.11%
2012-12-31	NT$861.62 Million ≈ $27.15 Million	NT$-23.58 Million ≈ $-742.77K	-0.027x	-161.99%
2011-12-31	NT$904.75 Million ≈ $28.50 Million	NT$39.94 Million ≈ $1.26 Million	0.044x	-83.72%
2010-12-31	NT$737.87 Million ≈ $23.25 Million	NT$200.03 Million ≈ $6.30 Million	0.271x	+58.78%
2009-12-31	NT$635.68 Million ≈ $20.03 Million	NT$108.53 Million ≈ $3.42 Million	0.171x	+3.44%
2008-12-31	NT$609.60 Million ≈ $19.21 Million	NT$100.62 Million ≈ $3.17 Million	0.165x	+99.72%
2007-12-31	NT$524.64 Million ≈ $16.53 Million	NT$43.36 Million ≈ $1.37 Million	0.083x	+29.07%
2006-12-31	NT$461.75 Million ≈ $14.55 Million	NT$29.56 Million ≈ $931.43K	0.064x	+94.99%
2005-12-31	NT$290.14 Million ≈ $9.14 Million	NT$9.53 Million ≈ $300.15K	0.033x	--

About GenMont Biotech Inc

TW:3164 Taiwan Biotechnology

Market Cap

$46.47 Million

NT$1.48 Billion TWD

Market Cap Rank

#21977 Global

#1360 in Taiwan

Share Price

NT$17.15

Change (1 day)

+0.29%

52-Week Range

NT$15.60 - NT$18.70

All Time High

NT$30.54